A low-cost and highly sensitive lab-on-a-chip device that integrates fiber optic glucose sensors and that could improve diabetes diagnosis and monitoring is being developed.
Sensitivity of currently available tests for transmissible spongiform encephalopathies matched or exceeded by new timed amyloid seeding assay.
Fujitsu Laboratories Ltd. (Kawasaki, Japan) has developed a portable breath sensor that is able to quickly measure gas components in breath, which could facilitate faster disease diagnoses.
A group of researchers have engineered a pioneering method increasing shelf-life of microfluidic devices for disease monitoring in developing countries.
Highly sensitive nanofiber sensor arrays that can detect the concentration of volatile organic compounds in exhaled breath have been developed by researchers, and may assist in early disease diagnosis, including for diabetes and lung cancer.
A portable, paper-based electrochemical platform, developed by researchers at McGill University (Montreal, QC, Canada), may enable low-cost point-of-care diagnoses for HIV and hepatitis C virus co-infection, improving disease diagnoses and staging.
A team of researchers has developed an optical biosensor using nanostructured metamaterials that is 1 million times more sensitive than previous sensors.
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification
Researchers unveil a new printing method that uses plasma to print nanomaterials onto 3D objects, potentially enabling easier and cheaper manufacturing of biosensors.
With more than 16 years experience with Flow Cytometry and 6 years of experience in various CLIA environments Dr. Slusser will be instrumental in the continuing development and expansion of services offered within KCAS’s large molecule department.